Sreenivasa R. Chinni
Affiliations: | Cancer Biology | Wayne State University, Detroit, MI, United States |
Area:
Oncology, Molecular BiologyGoogle:
"Sreenivasa Chinni"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Radoiu C, Govindarajan B, Wang M, et al. (2023) A Novel Interaction between Chemokine and Phosphoinositide Signaling in Metastatic Prostate Cancer. Medical Research Archives. 11 |
| Govindarajan B, Sbrissa D, Pressprich M, et al. (2023) Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth. Scientific Reports. 13: 20634 |
| Govindarajan B, Sbrissa D, Pressprich M, et al. (2023) Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth. Research Square |
| Mazzu YZ, Liao Y, Nandakumar S, et al. (2021) Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity. Molecular Oncology |
| Chinni SR. (2021) Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer. Ebiomedicine. 74: 103696 |
| Vaishampayan UN, Heilbrun LK, Monk P, et al. (2021) Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial. Jama Network Open. 4: e2034633 |
| Powell IJ, Chinni SR, Reddy SS, et al. (2020) Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update. Urologic Oncology |
| Semaan L, Mander N, Cher ML, et al. (2019) TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model. Bmc Cancer. 19: 972 |
| Sbrissa D, Semaan L, Govindarajan B, et al. (2018) A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells. Oncogene |
| Vaishampayan UN, Heilbrun LK, Monk P, et al. (2018) Randomized trial of enzalutamide versus bicalutamide in combination with androgen deprivation in metastatic hormone sensitive prostate cancer: A Prostate Cancer Clinical Trials Consortium trial. Journal of Clinical Oncology. 36: 190-190 |